Stem-like CD8+ T cells preserve HBV-specific responses in HBV/HIV co-infection

People with well-controlled HBV/HIV co-infection maintain robust CD8⁺ T cell responses with preserved stem-like properties supporting antiviral function. These results challenge assumptions about additive immune dysfunction in dual chronic infections and highlight the need for tailored immune-modulatory therapies.